Manufacturer of Controlled Substances Registration: American Radiolabeled Chemicals, Inc., 45551-45552 [2015-18692]
Download as PDF
<![CDATA[
45551
Federal Register / Vol. 80, No. 146 / Thursday, July 30, 2015 / Notices
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Cambridge Isotope
Lab to manufacture the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of morphine (9300), a
basic class of controlled substance listed
in schedule II.
The company plans to utilize small
quantities of the listed controlled
substance in the preparation of
analytical standards.
Dated: July 23, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–18693 Filed 7–29–15; 8:45 am]
BILLING CODE 4410–09P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Stepan Company
ACTION:
Dated: July 23, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Notice of registration.
Stepan Company applied to
be registered as an importer of certain
basic class of controlled substances. The
Drug Enforcement Administration
(DEA) grants Stepan Company
registration as an importer of this
controlled substance.
SUPPLEMENTARY INFORMATION: By notice
dated April 14, 2015, and published in
SUMMARY:
the Federal Register on April 22, 2015,
80 FR 22561, Stepan Company, Natural
Products Dept., 100 W. Hunter Avenue,
Maywood, New Jersey 07607 applied to
be registered as an importer of a certain
basic class of controlled substance.
Comments and request for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Stepan Company to import the basic
class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of coca leaves (9040) a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance to
manufacture bulk controlled substances
for distribution to its customers.
[FR Doc. 2015–18691 Filed 7–29–15; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: American
Radiolabeled Chemicals, Inc.
ACTION:
Notice of registration.
American Radiolabeled
Chemicals, Inc. applied to be registered
as a manufacturer of certain basic
classes of controlled substances. The
Drug Enforcement Administration
(DEA) grants American Radiolabeled
Chemicals, Inc. registration as a
manufacturer of those controlled
substances.
SUMMARY:
By notice
dated January 28, 2015, and published
in the Federal Register on February 5,
2015, 80 FR 6547, American
Radiolabeled Chemicals, Inc., 101 Arc
Drive, St. Louis, Missouri 63146 applied
to be registered as a manufacturer of
certain basic classes of controlled
substances. No comments or objections
were submitted to this notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of American
Radiolabeled Chemicals, Inc. to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed:
SUPPLEMENTARY INFORMATION:
Lhorne on DSK7TPTVN1PROD with NOTICES
Controlled substance
Schedule
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
Ibogaine (7260) ...........................................................................................................................................................................................
Lysergic Acid Diethylamide (7315) ..............................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ...............................................................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
VerDate Sep<11>2014
14:54 Jul 29, 2015
Jkt 235001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
E:\FR\FM\30JYN1.SGM
30JYN1
I
I
I
I
I
I
I
I
I
II
II
II
II
45552
Federal Register / Vol. 80, No. 146 / Thursday, July 30, 2015 / Notices
Controlled substance
Schedule
Phenylacetone (8501) .................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Hydrocodone (9193) ....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Oripavine (9330) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
Phenazocine (9715) ....................................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
Dated: July 23, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–18692 Filed 7–29–15; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Pharmacore
ACTION:
Notice of registration.
Pharmacore applied to be
registered as an importer of a certain
basic class of controlled substance. The
Drug Enforcement Administration
(DEA) grants Pharmacore registration as
an importer of this controlled substance.
SUPPLEMENTARY INFORMATION: By notice
dated April 14, 2015, and published in
the Federal Register on April 22, 2015,
80 FR 22553, Pharmacore, 4180
Mendenhall Oaks Parkway, High Point,
North Carolina 27265 applied to be
registered as an importer of a certain
basic class of controlled substance.
Comments and request for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Pharmacore to import the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
Lhorne on DSK7TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
14:54 Jul 29, 2015
Jkt 235001
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of poppy straw concentrate
(9670), a basic class of controlled
substance listed in schedule II.
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
intermediates for sale to its customers.
Dated: July 23, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–18690 Filed 7–29–15; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1110—NEW]
Agency Information Collection
Activities;Proposed eCollection
eComments Requested; Approval of
an Existing Collection in Use Without
an OMB Control Number; Records
Modification Form (FD–1115)
Federal Bureau of
Investigation, Department of Justice.
ACTION: 30-day notice.
AGENCY:
The Department of Justice
(DOJ), Federal Bureau of Investigation
(FBI), Criminal Justice Information
Services (CJIS) Division will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
SUMMARY:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the 80 FR
30269, on May 27, 2015, allowing for a
60 day comment period.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until August 31, 2015.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact the Office of Management and
Budget, Office of Information and
Regulatory Affairs, Attention
Department of Justice Desk Officer,
Washington, DC, 20503. Additionally,
comments may be submitted via email
to OIRA_submission@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 80, Number 146 (Thursday, July 30, 2015)]
[Notices]
[Pages 45551-45552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18692]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: American
Radiolabeled Chemicals, Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: American Radiolabeled Chemicals, Inc. applied to be registered
as a manufacturer of certain basic classes of controlled substances.
The Drug Enforcement Administration (DEA) grants American Radiolabeled
Chemicals, Inc. registration as a manufacturer of those controlled
substances.
SUPPLEMENTARY INFORMATION: By notice dated January 28, 2015, and
published in the Federal Register on February 5, 2015, 80 FR 6547,
American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis,
Missouri 63146 applied to be registered as a manufacturer of certain
basic classes of controlled substances. No comments or objections were
submitted to this notice.
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of American Radiolabeled Chemicals,
Inc. to manufacture the basic classes of controlled substances is
consistent with the public interest and with United States obligations
under international treaties, conventions, or protocols in effect on
May 1, 1971. The DEA investigated the company's maintenance of
effective controls against diversion by inspecting and testing the
company's physical security systems, verifying the company's compliance
with state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above-named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)............ I
Ibogaine (7260)............................. I
Lysergic Acid Diethylamide (7315)........... I
Tetrahydrocannabinols (7370)................ I
Dimethyltryptamine (7435)................... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
Dihydromorphine (9145)...................... I
Heroin (9200)............................... I
Normorphine (9313).......................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Amobarbital (2125).......................... II
Phencyclidine (7471)........................ II
[[Page 45552]]
Phenylacetone (8501)........................ II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Ecgonine (9180)............................. II
Hydrocodone (9193).......................... II
Meperidine (9230)........................... II
Metazocine (9240)........................... II
Methadone (9250)............................ II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................. II
Oripavine (9330)............................ II
Thebaine (9333)............................. II
Oxymorphone (9652).......................... II
Phenazocine (9715).......................... II
Carfentanil (9743).......................... II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances as radiolabeled compounds for biochemical
research.
Dated: July 23, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-18692 Filed 7-29-15; 8:45 am]
BILLING CODE P
